Imaging DNA damage response by γH2AX in vivo predicts treatment response to Lutetium-177 radioligand therapy and suggests senescence as a therapeutically desirable outcome

Rationale: An effective absorbed dose response relationship is yet to be established for Lutetium-177 based radionuclide therapies such as (177)Lu-DOTATATE and (177)Lu-PSMA. The inherent biological heterogeneity of neuroendocrine and prostate cancers may make the prospect of establishing cohort-base...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Neill, Edward, Mosley, Michael, Cornelissen, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008745/
https://www.ncbi.nlm.nih.gov/pubmed/36923536
http://dx.doi.org/10.7150/thno.82101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008745/
https://www.ncbi.nlm.nih.gov/pubmed/36923536
http://dx.doi.org/10.7150/thno.82101

Ejemplares similares